Beruflich Dokumente
Kultur Dokumente
DEFINITION (K/DOQI)
Renal artery disease (RAD) is defined as a stenosis of the main renal artery or its proximal branches. Significant RAD
anatomically if there is a >50% stenosis of the lumen hemodynamically if the stenosis exceeds 75%.
clinically significant stenosis
SIGNIFICANCE
The prevalence and incidence of chronic kidney disease (CKD) are increasing. ESRD incidente patients rates are 168 in Canada, 1 250 in the USA and 85.7 in Romania. It is of importance to search for reversible causes of CKD. Renal artery stenosis (RAS) may account for 5 22% of patients with ESRD who are older than 50 years; Correction of ischemic lesions can reverse decrease in renal function and improve CV outcomes.
3
PREVALENCE
RAS due to: Atherosclerotic renovascular disease (ARVD >90%) Fibromuscular disease (FMD). Takayashus arteritis up to 60% (Indian subcontinent and the Far East)
autopsy studies - 450% of subjects, (16.4 vs. 5.5% > 60 vs < 60 years) aortic angiography - 38% of patients with aortic aneurysm, - 33% in those with aortic occlusive disease - 39% lower limb occlusive disease. cardiac catheterization - 1429% prevalence in coronary disease - < 10% in normal coronary arteries .
4
PATHOGENY (1)
ARVD is associated with three major clinical syndromes: ischemic renal disease hypertension. Renal failure (acute and chronic)
PATHOGENY (2)
Interrelation among Renal-Artery Stenosis, Hypertension, and Chronic Renal Failure Robert D. Safian, M.D., and Stephen C. Textor, M.D NEJM, Nr 6, vol 344:431-442, 2001 6
Nephrol Dial Transplant (2007) 22: 10021006; Atherosclerotic renovascular disease: beyond the renal artery stenosis; Pascal Meier, Jerome Rossert, Pierre-Francois Plouin ,Michel Burnier
ISCHAEMIC NEPHROPATHY
(1)
Interstitial fibrosis, tubular atrophy, glomerulosclerosis (including focal segmental glomerulosclerosis), periglomerular fibrosis arteriolar abnormalities (hialinosclerosis, atheroembolism). atherosclerotic nephropathy
Histologic studies of interstitial fibrosis (Trichrome stain, left two (a) low magnification and high magnification (b) and immunohistochemistry for NF-kappa-B (NFkB, right) in swine. The presence of renal artery stenosis (RAS) induces both interstitial fibrosis and NFkB), which is accelerated by the presence of high cholesterol levels (HC). (Chade AR, Rodriguez-Porcel M, Grande JP, Krier JD, Lerman A, Romero JC, Napoli C, Lerman LO: Distinct renal injury in early 9 atherosclerosis and renovascular disease. Circulation 106: 11651171, 2002)
ISCHAEMIC NEPHROPATHY
(3)
Acute renal failure bilateral renal arterial occlusion (RAO) intra-renal cholesterol atheroembolization damage from radiocontrast agents during intraarterial angiography hypovolaemia, often with concurrent diuretic use concurrent use of angiotensin-converting enzyme inhibitors (ACE-I) or angiotensin II receptor blockers (AII-RBs).
10
ARVD AND ITS ASSOCIATION WITH HEART AND OTHER VASCULAR DISEASES (1)
Coronary artery disease RAS is associated with more severe and extensive coronary artery disease ? effects of renal ischemia or is a marker for advanced atherosclerosis and cardiovascular risk?
11
ARVD AND ITS ASSOCIATION WITH HEART AND OTHER VASCULAR DISEASES (2)
Cardiac dysfunction including flash pulmonary oedema presenting clinical syndrome in 41% of patients with bilateral ARAS and in 12% of patients with unilateral ARAS. angiotensin II promoted sodium retention and increase in pulmonary microcirculation permeability ARVD patients were found to have significantly higher prevalence left ventricular hypertrophy (78.5% compared with 46.0%) left ventricular diastolic dysfunction (40.5% compared with 12.0%), greater left ventricular mass index (183 74 g/m2 12 compared with 116 33 g/m2).
ARVD AND ITS ASSOCIATION WITH HEART AND OTHER VASCULAR DISEASES (3)
Aortic aneurysm and peripheral vascular disease Prevalence of ARVD in patients undergoing aortography for intermittent claudication varying from 33%, 39%, 44.9%; Cerebrovascular disease The coexistence of ARVD in patients who have stroke and/or carotid stenoses In an autopsy series of 346 cases of brain infarcts >75% RAS was found in 10.4% of subjects and carotid artery stenosis in 33.6%. Patients with carotid stenosis were more likely to have ARVD than those without carotid disease. Conversely, ARVD patients are more likely to have 13 carotid disease.
ARVD AND ITS ASSOCIATION WITH HEART AND OTHER VASCULAR DISEASES (4)
ARVD and hypertension ARVD is found in 25% of all cases of hypertension 90% of patients with ARVD are hypertensive. hypertension precedes ARVD development in many cases.
14
Renal abnormalities
Unexplained renal failure in patients aged >50 years Elevation in plasma creatinine level after the initiation of ACE-I or AII-RB therapy (> 30% increase in serum creatinine) Asymmetrical kidneys on imaging
15
16
DRASTIC The most powerful predictors for detecting lesions of at least 50%: age, symptomatic vascular disease, elevated cholesterol the presence of an abdominal bruit.
17
MR renal angiogram showing tight stenosis of the right renal artery and occlusion of the left 19 renal artery
21
22
Few topics provoke more controversy between nephrologists and interventional cardiologists than management of atherosclerotic renovascular disease
23
25
26
Second-line agent
Thiazide diuretic Combinations with ARB/ACE may be available Use loop diuretics for patients with serum creatinine 2 mg/dL
27
Goal of therapy low-density lipoprotein cholesterol <100 mg/dL some suggesting a target of < 70 mg/dL Statins effects independent of lipid-lowering stabilize, slow progression or even induce regression of atherosclerotic plaque reduction of proteinuria
28
29
Effect of the Medical Therapy Intervention reduce cardiovascular risk progression to end-stage renal disease actually does not respond very well to medical therapy
30
Surgical treatment revascularization nephrectomy of small kidneys with relatively complete arterial occlusion.
31
Definite indications for renal revascularization Recurrent flash pulmonary oedema Severe hypertension resistant to all medical therapy. When a patient who requires ACE-I or AII-RB therapy (e.g. for cardiac failure) presents with significant ACE-I-related uraemia. RAO in a reasonably sized kidney
33
35
NEPHROSCLEROSIS
36
Definition
clinical syndrome characterized by longterm essential hypertension, hypertensive retinopathy, left ventricular hypertrophy, minimal proteinuria, and progressive renal insufficiency
37
Pathophysiology
Glomerular ischemia:chronic hypertension result in narrowing of preglomerular arteries and arterioles, with a consequent reduction in glomerular blood flow Glomerulosclerosis induce by glomerular hypertension and glomerular hyperfiltration
38
Genetics
a significant loss in kidney function was observed in black people despite similar levels of BP control polymorphism in the angiotensinconverting enzyme (ACE) gene, the DD genotype increased angiotensinogen mutations
39
Frequency
USA: 1985-2005, adjusted rates of ESRD caused by hypertension increased 140% Hypertensive nephrosclerosis accounts for more than one third of patients on hemodialysis. Europe: 12% of new patients starting renal replacement therapy
40
Race
In black people, hypertensive nephrosclerosis occurs earlier, is more severe, and more often causes ESRD (36.8% in black patients vs 26% in white patients).
41
Age
The diagnosis of hypertensive nephrosclerosis increases with advancing age. The peak age for the development of ESRD in white patients is 65 years and older, while the peak age is 45-65 years in black people
42
DIAGNOSIS
Long-standing or very severe hypertension Black race Hypertension preceding renal dysfunction Hypertension diagnosed prior to the onset of proteinuria No evidence of another renal disease Biopsy findings compatible with the diagnosis Proteinuria less than 0.5 g/d Hypertensive retinal changes Left ventricular hypertrophy
43
Imaging Studies
echocardiogram to assess left ventricular size. Renal imaging with either an ultrasound or an intravenous pyelogram reveals that kidney size is usually symmetric and may be normal or modestly reduced. The renal calices and pelves are normal. Renal asymmetry or irregularities in the contour raise the possibility that hypertension could be secondary to renal artery stenosis or reflux nephropathy ECG typically shows left ventricular hypertrophy; the sensitivity of ECG in helping to detect left ventricular hypertrophy may be as low as 22%.
46
49
TREATMENT (I)
BP goal of less than 130/80 mm Hg to preserve renal function and to reduce cardiovascular events in patients with hypertension and diabetes. Lower BPs are recommended for patients with proteinuria greater than 1 g/d and renal insufficiency, regardless of etiology
ACE inhibitors
Effects and indications Reduce proteinuria Specific renal protective effect both in diabetic and nondiabetic renal impairment Reduce morbidity and mortality rates in congestive heart failure Monotherapy less effective in older patients (>50 y) Larger doses required in black patients Inhibit or blunt all adverse metabolic effects of thiazides Dose reduction required in renal failure Reduce left ventricular hypertrophy and thirst Adverse effects Cough (approximately 10%) Angioedema (rare) Hyperkalemia (especially in renal tubular acidosis type IV) GFR reduction in patients with impaired renal function May precipitate acute renal failure in patients with renal artery stenosis 50 Interfere with breakdown of bradykinin Contraindicated in pregnancy
TREATMENT (II)
Angiotensin II receptor antagonists Effects and indications Reduce proteinuria Indicated in patients intolerant of ACE inhibitors Can be used in combination with an ACE inhibitor Do not cause cough Reduce left ventricular hypertrophy and thirst similarly to ACE inhibitors Do not interfere with breakdown of bradykinin
Adverse effects Hyperkalemia May reduce GFR in patients with impaired renal function May precipitate acute renal failure in patient with renal artery stenosis Angioedema (rare) Contraindicated in pregnancy Data in black patients limited
51
TREATMENT (III)
Calcium channel blockers Effects and indications Effective as monotherapy in black patients and elderly patients Potentiate ACE inhibitor effects Renal protection not proven Reduce morbidity and mortality rates in congestive heart failure Indicated in patients with diastolic dysfunction No change in dose with renal failure Adverse effects Possible increase in cardiovascular mortality rate with short-acting dihydropyridines Edema Constipation (verapamil) Profound bradycardia possible when verapamil and diltiazem used in combination with a beta-blocker
52
55